Autopsy report · NCT02004951

BATTLE Trial: Bare Metal Stent Versus Paclitaxel Eluting Stent in the Setting of Primary Stenting of Intermediate Length Femoropopliteal Lesions

“Batch recall for Misago Terumo self-expanding peripheral stent systems.(withdrawal from the market)”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 6 years 4 months before it stopped.
• 186 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Nantes University Hospital

Sponsor type

University, hospital or other

Conditions

Peripheral Arterial Disease; Femoropopliteal Lesions

Interventions

Misago RX; Zilver PTX

Participants

186

Sites

11

Countries

France

Trials that died the same way

• Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions
  “The NEVO™ stent will not be commercialized. Cordis decided to close the study after 3 years. This decision took the absence of safety signals into account.” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.